Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 26 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 11001592

    DNA polymerase IIIC inhibitors and use thereof

    Acurx Pharmaceuticals, Inc. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  2. US 10993941

    Methods for the administration of certain VMAT2 inhibitors

    Neurocrine Biosciences, Inc. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  3. US 10995100

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  4. US 10995061

    SPAK kinase inhibitors as neuroprotective agents

    United States Government as represented by the Department of Veterans Affairs · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  5. US 10993948

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  6. US 10993936

    Method of treating one or more symptoms of pulmonary fibrosis by administering inhibitors of nicotinamide phosphoribotransferase

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  7. US 10995089

    Zaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  8. US 10988465

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  9. US 10988450

    3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Valo Early Discovery, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  10. US 10987354

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  11. US 10988477

    GCN2 inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  12. US 10988458

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  13. US 10988441

    Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

    Valo Early Discovery, Inc. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  14. US 10981915

    Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

    Valo Early Discovery, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  15. US 10981906

    Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same

    Aclaris Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  16. US 10980889

    C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

    Revolution Medicines, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  17. US 10980793

    Methods of treating cancer with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  18. US 10980797

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Corcept Therapeutics Incorporated · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  19. US 10981896

    Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  20. US 10973830

    Substituted quinoxaline DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  21. US 10975094

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  22. US 10975167

    Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  23. US 10968180

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  24. US 10968205

    Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted